[Adrenal cortex extract in the supportive therapy of neoplasm patients].
A high-title (2000 UCD) adrenal cortex extract was used in the support management of 30 neoplastic patients. Evaluation was based on performance status (PS) according to Karnofsky and symptom incidence before and after the treatment. PS improved in 30%. There was a marked reduction in asthenia and anorexia, with significant changes in headache, nausea, and vomiting. Blood pressure, heart rate, and the blood chemistry picture were not altered.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D011282:Pregnenediones / Q000627:therapeutic use*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D004338:Drug Combinations; D011282:Pregnenediones; C028594:maxicortex 2000
Un estratto di corteccia surrenale nella terapia di supporto dei pazienti neoplastici.